Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

NCT00075946

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
View all 483 locations
View Trial Details
Completed

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

NCT03543813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • University of Southern California Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 25 locations
View Trial Details
Completed

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

NCT02658968

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +29 more
Locations
  • University of California, San Diego (UCSD) - Moores Cancer Center San Diego, California, United States
  • University of California, San Francisco (UCSF) - Innovation, Technology & Alliances San Francisco, California, United States
  • Sylvester Comprehensive Cancer Centre Miami, Florida, United States
  • Klinikum rechts der Isar der TU München Munich, Germany
View Trial Details
Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations
  • City of Hope ( Site 0010) Duarte, California, United States
  • University of California - San Diego ( Site 0003) La Jolla, California, United States
  • UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States
  • University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States
View all 14 locations
View Trial Details
Completed

Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma

NCT03399513

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • HELIOS Hospital Berlin-Buch Berlin, Germany
  • Hospital Chemnitz Chemnitz, Germany
  • University Hospital Cologne Cologne, Germany
  • University Hospital Göttingen Göttingen, Germany
View Trial Details

Related conditions